Pharma stocks survive market rout on tariff exemption, but uncertainty continues
Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from ...
Pharma Dodges The Tariff Bullet — But For How Long?
As long as pharmaceutical tariffs are being considered, their potential threat to the pharmaceutical industry and the people ...
STAT17h
Pharmalittle: We’re reading about a pharma tariff exception, FDA inspection cutbacks, and more
The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...
USA Today7d
Pharma industry races to stockpile medicines before potential tariffs
The second executive at a drugmaker said his company was "stockpiling" in the United States, the pharma industry's ...
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.
RTÉ Ireland1dOpinion
Pharma industry may be golden goose ready for plucking
Tariffs are one way for Donald Trump to achieve tax cuts, and Irish-based pharma industry may be a golden goose ready for ...
Explore more
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Kiran Shaw welcomes US pharma tariff exemption
BENGALURU: In a boost to India’s pharmaceutical industry, the US government has decided to exempt pharma products from ...
The Future of Pharmaceuticals: How Cannabinoids Are Redefining the Industry
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions.